34465068|PMC8561033
{'Chemical', 'Disease', 'Species'}
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had a tremendous impact on healthcare systems worldwide. The rapid antigen test is relatively cheaper than the RT-PCR test (5.7 vs. 10.8 USD), and the sensitivity is reported to be 60.5-72.1%, and the specificity is 98.7-99.5%.At the time of the survey, more than half of respondents (54.8%, 34 of 62) conducted an RT-PCR test in patients for emergent neurointervention, and 45.2% (28 of 62) were selectively performed in patients with suspicious COVID-19 symptoms. Clinical trials of neurointervention have been disrupted following COVID-19 according to the survey by Rai et al. (